Clinical Trial Detail

NCT ID NCT03811652
Title A Multiple Ascending Dose Study of MEDI7247 in Advanced or Metastatic Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors MedImmune LLC
Indications

lung small cell carcinoma

head and neck squamous cell carcinoma

lung squamous cell carcinoma

Advanced Solid Tumor

rectum adenocarcinoma

prostate cancer

colon adenocarcinoma

pancreatic ductal adenocarcinoma

Therapies

MEDI7247

Age Groups: senior adult

No variant requirements are available.